Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,545 across all filing types
Latest filing 2022-11-03 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 4 pages 215.9KB
Regulatory Filings
2022-11-03 English
CSL Highlights Progress Across Strong R&D Pipeline 97 pages 10.8MB
Regulatory Filings
2022-11-02 English
Licence Agreement - Next Generation mRNA Vaccine Technology 2 pages 130.3KB
Regulatory Filings
2022-11-01 English
CSL Notice of Research & Development Investor Briefing 1
Regulatory Filings
2022-10-30 English
Change of Director's Interest Notice 3 pages 210.3KB
Regulatory Filings
2022-10-24 English
Change of Director's Interest Notice 7 pages 235.1KB
Regulatory Filings
2022-10-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.